Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Condensed Consolidated Statements of Operations        
Revenues $ 33,428 $ 28,564 $ 79,805 $ 78,550
Cost of goods sold 5,697 4,510 16,118 12,468
Gross profit 27,731 24,054 63,687 66,082
Costs and expenses:        
Sales and marketing 17,726 18,245 49,854 53,146
Research and development 4,230 4,181 12,915 12,602
General and administrative 6,820 7,740 18,726 24,321
Total costs and expenses 28,776 30,166 81,495 90,069
Loss from operations (1,045) (6,112) (17,808) (23,987)
Other income (expense):        
Investment income 28 555 576 1,925
Interest expense (397) (7) (459) (32)
Change in fair value of derivatives (71)   (71)  
Other (expense)/income 6 (7) (14) (3)
Total other income (expense), net (434) 541 32 1,890
Net Loss $ (1,479) $ (5,571) $ (17,776) $ (22,097)
Weighted average common shares outstanding - basic and diluted 40,093,588 39,340,492 39,873,167 39,151,218
Loss per common share - basic and diluted $ (0.04) $ (0.14) $ (0.45) $ (0.56)